Ki16425, supplied by Echelon Biosciences, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
Average 85 stars, based on 1 article reviews
Price from $9.99 to $1999.99
1) Product Images from "Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy"
Article Title: Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy
Figure Legend Snippet: ]. LPA (1 µmol/l) or BVi was added for 2 days; the treatments were renewed every 12 h. The vessel length was measured before and after the indicated treatments. Data shown are the means±SEM of four independent experiments. ( a ) Treatment with BVi induced regression comparable with that mediated by LPA. Addition of the LPA receptor inhibitors BrP-LPA (10 µmol/l) or Ki16425 (5 µmol/l) in combination with BVi inhibited regression. Addition of the inhibitors alone had no effect. The percentage stability is the ratio of vessel lengths before and after treatment. * p